#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1892	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2604	212.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1901	1901	T	276	T,C	242,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1892	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2604	212.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1635	1635	C	244	C	207	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1892	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2604	212.0	0	HET	.	.	.	A705G	.	705	705	A	1156	1156	A	311	A,G	197,64	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3036	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3727	240.5	0	.	n	.	0	T665C	SNP	665	665	T	1118	1118	C	235	C,T,G	143,60,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3036	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3727	240.5	0	.	n	.	0	T695C	SNP	695	695	T	1148	1148	C	226	C,T,A	136,55,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3036	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3727	240.5	0	.	n	.	0	C1623T	SNP	1623	1623	C	2076	2076	T	263	T,C,A	164,53,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3036	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3727	240.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2424	2424	C	234	C	207	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3036	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3727	240.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2498	2498	A	248	A,G	215,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3036	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3727	240.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3050	3050	C	277	C	233	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3036	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3727	240.5	0	HET	.	.	.	G1337A	.	1337	1337	G	1790	1790	G	260	G,A	114,98	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	226	folP	855	855	100.0	folP.l6.c4.ctg.1	1979	33.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1183	1185	AGC	46;46;46	A;G;C	39;40;36	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	708	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3935	53.8	1	SNP	p	S91F	0	.	.	271	273	TCC	889	891	TCC	52;53;53	T;C;C	45;48;45	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	708	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3935	53.8	1	SNP	p	D95G	0	.	.	283	285	GAC	901	903	GAC	51;51;50	G;A;C	44;45;43	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	708	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3935	53.8	1	SNP	p	D95N	0	.	.	283	285	GAC	901	903	GAC	51;51;50	G;A;C	44;45;43	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	294	mtrR	633	633	99.37	mtrR.l15.c4.ctg.1	1936	45.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	785	787	ACC	69;70;71	A;C;C	61;61;66	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	294	mtrR	633	633	99.37	mtrR.l15.c4.ctg.1	1936	45.5	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	983	985	CAC	81;80;79	C;A;C,A	71;72;72,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	294	mtrR	633	633	99.37	mtrR.l15.c4.ctg.1	1936	45.5	1	SNP	p	G45D	0	.	.	133	135	GGC	803	805	GGC	78;78;79	G;G;C	64;67;66	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	194	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1381	41.8	0	.	n	.	0	G120A	SNP	120	120	G	708	708	A	72	A	61	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	50.9	1	SNP	p	D86N	0	.	.	256	258	GAC	722	724	GAC	56;57;58	G;A;C	44;47;44	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	50.9	1	SNP	p	S87R	0	.	.	259	261	AGT	725	727	AGT	58;59;59	A,C;G;T	47,1;49;47	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	50.9	1	SNP	p	S87W	0	.	.	259	261	AGT	725	727	AGT	58;59;59	A,C;G;T	47,1;49;47	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	50.9	1	SNP	p	S87I	0	.	.	259	261	AGT	725	727	AGT	58;59;59	A,C;G;T	47,1;49;47	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	50.9	1	SNP	p	S88P	0	.	.	262	264	TCC	728	730	TCC	59;59;59	T;C,A;C	47;47,1;46	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	520	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3053	50.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1771	1773	GGC	61;60;58	G;G,T;C	51;46,1;48	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1562	1564	GCA	58;57;57	G;C;A	50;47;47	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1565	1567	ATC	57;57;57	A;T;C,T	50;50;50,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1577	1579	GTG	57;57;57	G;T,G;G,T	53;49,1;52,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1577	1579	GTG	57;57;57	G;T,G;G,T	53;49,1;52,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2081	2083	ACC	51;52;52	A;C;C,T	42;46;42,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2135	2137	GCG	48;48;48	G;C,A;G	40;37,1;37	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2135	2137	GCG	48;48;48	G;C,A;G	40;37,1;37	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2258	2260	GGT	63;63;63	G;G;T	55;54;53	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2267	2269	GGC	58;58;57	G;G;C	48;50;46	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	47.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2285	2287	CCG	56;56;56	C;C;G	47;48;48	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	546	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3474	46.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1800	1802	CCG	37;37;37	C;C;G	31;32;33	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	336	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2414	41.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	928	928	C	40	C	36	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	342	porB1b	1047	1047	98.29	porB1b.l15.c4.ctg.1	2031	49.8	0	.	p	.	0	G120D	NONSYN	358	360	GGC	933	935	GAC	72;72;71	G;A;C	62;62;60	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	342	porB1b	1047	1047	98.29	porB1b.l15.c4.ctg.1	2031	49.8	0	.	p	.	0	Y254fs	FSHIFT	760	760	T	1335	1335	T	61	T	52	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	342	porB1b	1047	1047	98.29	porB1b.l15.c4.ctg.1	2031	49.8	1	SNP	p	A121D	1	.	.	361	363	GAC	936	938	GAC	71;71;72	G,T;A;C	59,1;59;63	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	342	porB1b	1047	1047	98.29	porB1b.l15.c4.ctg.1	2031	49.8	1	SNP	p	D121N	0	.	.	361	363	GAC	936	938	GAC	71;71;72	G,T;A;C	59,1;59;63	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	1190	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5406	65.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2274	2276	CAT	70;71;71	C,A;A;T	59,1;57;57	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	224	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1432	46.7	1	SNP	p	V57M	1	.	.	169	171	ATG	699	701	ATG	93;93;92	A;T,G;G	73;70,1;71	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	M177T	NONSYN	529	531	ATG	1262	1264	ACG	75;75;75	A;C;G	64;64;63	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	1283	1285	GAC	70;70;71	G;A;C	56;58;60	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1301	1303	ATG	70;70;70	A;T;G	60;59;57	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1313	1315	TCA	68;68;69	T,A;C;A	58,1;61;59	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1358	1360	CAG	67;67;66	C;A;G	59;58;58	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1379	1381	CTT	59;59;60	C;T;T	53;51;56	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1400	1402	AGT	57;57;57	A;G;T	49;51;50	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1469	1471	CCG	54;54;54	C;C;G	43;45;44	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1571	1573	TCG	37;37;36	T;C;G	33;34;34	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1742	1744	AAA	31;31;31	A;A;A	28;28;29	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1745	1747	AAG	31;31;31	A;A;G	28;29;27	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1760	1762	CAC	30;30;30	C;A;C	25;28;28	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1799	1801	GAA	28;28;28	G;A;A	24;27;25	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1877	1879	ACG	27;27;26	A;C;G	22;22;21	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1928	1930	ATT	26;26;25	A,T;T;T	20,1;21;19	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1931	1933	AGT	26;26;26	A;G;T	22;21;22	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1970	1972	CTA	30;30;30	C;T;A	24;24;24	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	2012	2014	AAT	31;29;30	A;A;T	27;27;27	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	2081	2083	TCA	36;36;35	T;C;A	33;34;32	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	2105	2107	ATG	37;37;37	A;T;G	36;36;36	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2399	2401	ACC	61;61;62	A;C;C,A	55;56;56,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	548	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3270	50.2	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2495	2497	GAA	78;79;79	G;A;A	64;67;65	.	Tetracycline resistance
